171 related articles for article (PubMed ID: 34579671)
1. Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.
van Hulst AM; Verwaaijen EJ; Fiocco MF; Pluijm SMF; Grootenhuis MA; Pieters R; van den Akker ELT; van den Heuvel-Eibrink MM
BMC Pediatr; 2021 Sep; 21(1):427. PubMed ID: 34579671
[TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM; van den Akker ELT; Verwaaijen EJ; Fiocco M; Rensen N; van Litsenburg RRL; Pluijm SMF; Zwaan CM; van Santen HM; Pieters R; Evers AWM; Grootenhuis MA; van den Heuvel-Eibrink MM
Eur J Cancer; 2023 Jul; 187():124-133. PubMed ID: 37149961
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
Warris LT; van den Heuvel-Eibrink MM; Aarsen FK; Pluijm SM; Bierings MB; van den Bos C; Zwaan CM; Thygesen HH; Tissing WJ; Veening MA; Pieters R; van den Akker EL
J Clin Oncol; 2016 Jul; 34(19):2287-93. PubMed ID: 27161966
[TBL] [Abstract][Full Text] [Related]
4. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
[TBL] [Abstract][Full Text] [Related]
5. Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
van Hulst AM; Grootenhuis MA; Verwaaijen EJ; van Litsenburg RRL; Li L; van Zelst BD; Broer L; Pluijm SMF; Pieters R; Fiocco M; van den Akker ELT; van den Heuvel-Eibrink MM
JCO Precis Oncol; 2023 Jun; 7():e2200678. PubMed ID: 37343203
[TBL] [Abstract][Full Text] [Related]
6. Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
Zhang D; Gu M
Eur J Cancer; 2023 Sep; 191():112979. PubMed ID: 37532597
[No Abstract] [Full Text] [Related]
7. Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
van Hulst AM; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
Eur J Cancer; 2023 Sep; 191():112980. PubMed ID: 37574396
[No Abstract] [Full Text] [Related]
8. The DEXA-CORT trial: study protocol of a randomised placebo-controlled trial of hydrocortisone in patients with brain tumour on the prevention of neuropsychiatric adverse effects caused by perioperative dexamethasone.
Koning ACAM; Satoer DD; Vinkers CH; Zamanipoor Najafabadi AH; Biermasz NR; Nandoe Tewarie RDS; Moojen WA; van Rossum EFC; Dirven CMF; Pereira AM; van Furth WR; Meijer OC
BMJ Open; 2021 Dec; 11(12):e054405. PubMed ID: 37057711
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study.
Verwaaijen EJ; van Hulst A; Fiocco M; Hartman A; Grootenhuis M; Pluijm S; Pieters R; van den Akker E; van den Heuvel-Eibrink MM
JMIR Res Protoc; 2022 Apr; 11(4):e33517. PubMed ID: 35403603
[TBL] [Abstract][Full Text] [Related]
12. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
Eiser C; Davies H; Jenney M; Stride C; Glaser A
Pediatr Blood Cancer; 2006 Jan; 46(1):35-9. PubMed ID: 15926164
[TBL] [Abstract][Full Text] [Related]
13. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review.
Warris LT; van den Heuvel-Eibrink MM; den Hoed MA; Aarsen FK; Pieters R; van den Akker EL
Pediatr Blood Cancer; 2014 Jul; 61(7):1313-8. PubMed ID: 24532490
[TBL] [Abstract][Full Text] [Related]
14. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
Mrakotsky CM; Silverman LB; Dahlberg SE; Alyman MC; Sands SA; Queally JT; Miller TP; Cranston A; Neuberg DS; Sallan SE; Waber DP
Pediatr Blood Cancer; 2011 Sep; 57(3):492-8. PubMed ID: 21560226
[TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone for the prevention of a pain flare after palliative radiotherapy for painful bone metastases: a multicenter double-blind placebo-controlled randomized trial.
Westhoff PG; de Graeff A; Geerling JI; Reyners AK; van der Linden YM
BMC Cancer; 2014 May; 14():347. PubMed ID: 24885354
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
18. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
19. Protocol and biomarker strategy for a multi-site randomized controlled trial examining biological mechanisms and dosing of active music engagement in children with acute lymphoblastic leukemia and lymphoma and parents.
Robb SL; Russ KA; Holochwost SJ; Stegenga K; Perkins SM; Jacob SA; Henley AK; MacLean JA
BMC Complement Med Ther; 2023 Mar; 23(1):90. PubMed ID: 36973774
[TBL] [Abstract][Full Text] [Related]
20. Can dexamethasone improve postoperative sleep and postoperative delirium in elderly patients undergoing robot-assisted laparoscopic radical prostatectomy? Protocol for a prospective, randomized, double-blind, controlled study.
Shi Y; Sun Q; Wang Y; Chen C; Jin J; Wang W; Lu Y; Hua Y; Liu J; Bian J; Yi Z
Trials; 2023 Aug; 24(1):505. PubMed ID: 37550718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]